Document is current
Any future updates will be listed below
-
Authors
Calvaruso, Vincenza http://orcid.org/0000-0002-0287-1059
Mazzarelli, Chiara
Milazzo, Laura
Badia, Lorenzo
Pasulo, Luisa
Guaraldi, Giovanni
Lionetti, Raffaella
Villa, Erica
Borghi, Vanni
Carrai, Paola
Alberti, Alfredo
Biolato, Marco
Piai, Guido
Persico, Marcello
Santantonio, Teresa http://orcid.org/0000-0002-4342-6904
Felder, Martina
Angelico, Mario
Montalbano, Marzia
Mancusi, Rossella Letizia http://orcid.org/0000-0002-6448-6279
Grieco, Antonio
Angeli, Elena
D’Offizi, Gianpiero
Fagiuoli, Stefano
Belli, Luca
Verucchi, Gabriella
Puoti, Massimo
Craxì, Antonio
- License Information
-
More Information
Article History
Received: 24 August 2018
Accepted: 6 November 2018
First Online: 24 January 2019
Competing Interests
: Vincenza Calvaruso has received compensation as a member of the scientific advisory board of Abbvie, Gilead and Intercept; Lorenzo Badia has received compensation as a member of the scientific advisory board of Abbvie, Gilead and Bristol-Myers Squibb; Luisa Pasulo has received compensation as a member of the scientific advisory board of Abbvie; Alfredo Alberti has been funded by by Gilead, MSD, Abbvie, BMS; Marco Biolato has received travel grant from Abbvie, Brystol Myers Squibb and Gilead; Antonio Grieco received compensation as a member of the scientfic advisory board of Abbvie and travel grant from Abbvie, Gilead and Sofar; Gianpiero D’Offizi has consulted for Gilead and AbbVie and received compensation; Stefano Fagiuoli is a member of Speaker’ bureau for Gilead, Abbvie, MSD, Bayer, Novartis, BMS, Kedrion; Gabriella Verucchi has received compensation as a member of the scientific advisory board of Gilead, Abbvie, MSD, and has received research grant from Gilead; Massimo Puoti has received compensation as a member of temporary scientific advisory board of Gilead, Abbvie and MSD and he has consulted for Abbvie, MSD and Gilead Sciences; Antonio Craxì has received research grants from Abbvie, BMS, Gilead, Merck/MSD, Intercept and has received compensation as a member of the scientific advisory board of Abbvie, Achillon, BI, BMS, Gilead, GSK, Janssen, Merck, Novartis, Roche, MSD/Merck. The other authors declare no potential conflict of interest.
